Tag Archive for: EndoChoice

Former Director of Urologic Pathology/GI Pathology at Ameripath

Life Science Partner has recruited Jeremy Miller, MD, to lead the Pathology Lab at EndoChoice, a College of American Pathology (CAP) accredited lab focused on providing the highest level of quality and service to the GI community.

Miller joins EndoChoice after serving as Director of Urologic Pathology and GI Pathology at Ameripath, in addition to formerly serving as Chief Medical Officer for Platinum Pathology, a national GI and GU lab owned by Miller based out of Virginia.

“Miller has excellent training as a pathologist with broad surgical pathology training, he has worked directly under internationally-renowned Dr. Fenoglio-Preiser, one of the top GI leaders in the field,” states Tom Callaway, MD, President and Founder of Life Science Partner.  “He is an entrepreneurial leader in the field of high volume pathology with a can-do attitude that will fit with the corporate culture of EndoChoice.”

Miller earned a Bachelor of Science Degree in Engineering from Duke University and his MD from the Medical College of Georgia.  Miller completed his Fellowship in Genitourinary Surgical Pathology from the The Johns Hopkins Hospital.

Former Chief Financial Officer at INC Research 

Life Science Partner recruited David Gill, MBA to become Chief Financial Officer at EndoChoice. EndoChoice an Atlanta-based company providing physicians with gastrointestinal endoscopy, diagnostics, infection control and imaging products.

David Gill

He was most recently CFO of INC Research, a publicly traded contract research organization. Previously Gill served as the CFO for TransEnterix, leading a $55 M Series B financing, relocating the company headquarters, and leading planning to scale up GMP manufacturing. As CFO for CTI Molecular Imaging, he raised a total of $213 M including an initial public offering to finance the rapid growth. He established a strategic relationship with Siemens that led to the acquisition of the CTI for $1 B.

In his new role at EndoChoice, Gill will work closely with CEO Mark Gilreath to oversee all corporate financial operations. “Gill understands how to use debt, public markets, and private equity to generate significant return for shareholders,” stated Tom Callaway, MD, Founder and President of Life Science Partner. “He has excelled in companies with highly varied technologies and global operations.”

Gill earned his Bachelor Degree in Accounting from Wake Forest University and his MBA from Emory University Goizueta Business School.